BD announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe designed for patients with diabetes taking Humulin R U-500 insulin (regular insulin [human, rDNA origin]; Eli Lilly).

BD has issued a recall for the BD Insulin Syringes with the BD Ultra-Fine needle ½mL 12.7mm 30G, Cat (Ref) 328466 with Lot# 6291768. BD has issued a recall for the BD Insulin Syringes with the BD ...

Embecta (Nasdaq:EMBC) today announced an expansion of its partnership with Direct Relief to mark World Diabetes Day.

Expanded Partnership Will Increase Access to Diabetes Care for Communities Across the U.S. and Globally SANTA BARBARA, CA / ACCESS Newswire / November 14, 2025 / On World Diabetes Day, embecta Corp.

Medical technology company BD on Wednesday that it will invest $100 million in its plant in Holdrege to expand capacity for its insulin syringe manufacturing operations. The investment will be used ...

Some people with diabetes require insulin. They can manually administer this through several methods, such as syringes, which are available in different sizes with various-sized needles. There are ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD has increased its manufacturing capacity for critical ...

Corp., a large manufacturer of insulin injection devices, has expanded its partnership with Direct Relief, a leading humanitarian aid organization and large charitable insulin provider in the ...